0001209191-23-004457.txt : 20230123
0001209191-23-004457.hdr.sgml : 20230123
20230123171219
ACCESSION NUMBER: 0001209191-23-004457
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230123
FILED AS OF DATE: 20230123
DATE AS OF CHANGE: 20230123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Graham Michelle
CENTRAL INDEX KEY: 0001506315
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33451
FILM NUMBER: 23545202
MAIL ADDRESS:
STREET 1: 10000 WEHRLE DRIVE
CITY: CLARENCE
STATE: NY
ZIP: 14031
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALBIREO PHARMA, INC.
CENTRAL INDEX KEY: 0001322505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-415-4774
MAIL ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Biodel Inc
DATE OF NAME CHANGE: 20050331
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-23
0
0001322505
ALBIREO PHARMA, INC.
ALBO
0001506315
Graham Michelle
C/O ALBIREO PHARMA, INC.
53 STATE STREET, 19TH FLOOR
BOSTON
MA
02109
0
1
0
0
Chief Human Resources Officer
Common Stock
2023-01-23
4
S
0
102
43.80
D
24493
D
Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Represents 5,543 shares of common stock and 18,950 restricted stock units.
/s/ Jason Duncan, Attorney-in-fact
2023-01-23